Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylactic anticoagulants in managing embolic stroke.

S Wessler

    Geriatrics
    |March 1, 1987
    PubMed
    Summary

    Anticoagulant therapy for cardiac embolic stroke carries a high risk of hemorrhage, especially in elderly patients. Careful management of risk factors and low-dose anticoagulation are crucial for improving patient outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nanomaterial-microbe cross-talk: physicochemical principles and (patho)biological consequences.

    Chemical Society reviews·2018
    Same author

    THROMBOEMBOLIC DISORDERS.

    A listing of research in the cardiovascular field·2014
    Same author

    Exploiting nongenomic estrogen receptor-mediated signaling for the Development of pathway-selective Estrogen receptor ligands.

    Ernst Schering Foundation symposium proceedings·2007
    Same author

    Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility.

    Oncogene·2006
    Same author

    The genome of black cottonwood, Populus trichocarpa (Torr. & Gray).

    Science (New York, N.Y.)·2006
    Same author

    Transposable element (TE) display and rapid detection of TE insertion polymorphism in the Anopheles gambiae species complex.

    Insect molecular biology·2003

    Area of Science:

    • Cardiovascular Medicine
    • Neurology
    • Pharmacology

    Background:

    • Anticoagulant therapy is essential for preventing cardiac embolic stroke.
    • Hemorrhage, particularly cerebral hemorrhage, is a significant risk associated with anticoagulation, especially in the elderly population.
    • Optimizing the benefit/risk ratio of anticoagulation requires careful consideration of multiple patient-specific factors.

    Purpose of the Study:

    • To identify key factors influencing the benefit/risk ratio of anticoagulant therapy in patients with cardiac embolic stroke.
    • To provide recommendations for managing anticoagulation to minimize hemorrhagic complications while maintaining therapeutic efficacy.

    Main Methods:

    • Review of clinical factors impacting anticoagulation safety and efficacy.
    • Consideration of hemostatic competence, blood pressure, drug interactions, fall risk, surgical timing, diet, and aspirin use.
    • Evaluation of anticoagulant intensity, specifically heparin dosage and warfarin's prothrombin time ratio.

    Main Results:

    • Hemorrhagic complications, especially cerebral hemorrhage, are the primary concern with anticoagulant therapy in cardiac embolic stroke.
    • Several factors, including patient characteristics and concomitant medications, significantly influence the risk of bleeding.
    • Current evidence suggests a prudent approach involves limiting heparin to a maximum of 20,000 units/24 hours.

    Conclusions:

    • Low-dose anticoagulation strategies are recommended to improve the benefit/risk profile.
    • Limiting warfarin maintenance to a low-dose prothrombin time ratio of 1.5 is advised.
    • Comprehensive management of risk factors is essential for safe and effective anticoagulation in cardiac embolic stroke patients.

    Related Experiment Videos